Sanda Pharmaprojects Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 50.00 K
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.72 M
- Revenue Growth 3.95%
- Profit Growth -32.47%
- Ebitda 42.50%
- Net Worth 51.04%
- Total Assets 19.15%
About Sanda Pharmaprojects
Sanda Pharmaprojects Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 August 2019 (Five years and six months 8 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 50.00 K .
The company currently has active open charges totaling ₹3.72 M.
Sandeep Patil and Sheetal Girase serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24239MH2019PTC328946
-
Company No.
328946
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Aug 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sanda Pharmaprojects?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Patil
|
Director | 06-Aug-2019 | Current |
|
Sheetal Girase
|
Director | 06-Aug-2019 | Current |
Financial Performance of Sanda Pharmaprojects.
Sanda Pharmaprojects Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.95% increase. The company also saw a substantial fall in profitability, with a 32.47% decrease in profit. The company's net worth Soared by an impressive increase of 51.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanda Pharmaprojects?
Unlock access to Sanda Pharmaprojects's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.72 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.22 Cr
- Hdfc Bank Limited : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2022 | Hdfc Bank Limited | ₹1.56 M | Open |
| 15 Aug 2022 | Axis Bank Limited | ₹2.16 M | Open |
How Many Employees Work at Sanda Pharmaprojects?
Unlock and access historical data on people associated with Sanda Pharmaprojects, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanda Pharmaprojects, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanda Pharmaprojects's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.